Back HIV/Hepatitis Coinfection

Coinfection

HIV/HBV Coinfection Raises Risk of AIDS Progression and Death

Coinfection with hepatitis B virus (HBV) nearly doubled the risk of progression to AIDS or death among people recently infected with HIV, according to a study described in the December 5, 2011, advance online edition of the Journal of Infectious Diseases.

Read more:

CDC Offers New HIV and Hepatitis Coinfection Fact Sheet

The U.S. Centers for Disease Control and Prevention (CDC) have produced a new fact sheet providing information about viral hepatitis in people with HIV.alt

Read more:

Alarming Rate of Hepatitis C Re-infection among HIV+ Gay Men

One-third of HIV positive men who have sex with men (MSM) who were treated for acute hepatitis C virus (HCV) infection in Amsterdam became re-infected within 2 years, indicating a need for improved prevention efforts, according to a recent report.alt

Read more:

AASLD 2011: Upping Ribavirin Dose Does Not Increase Interferon Effectiveness in HIV/HCV Coinfected Patients

Starting hepatitis C treatment with a double dose of ribavirin plus erythropoietin to manage anemia did not lead to higher rates of sustained response to interferon-based therapy in HIV/HCV coinfected people, researchers reported at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) this month in San Francisco.alt

Read more:

Treatment of HIV/HCV Coinfected People with Compensated Liver Cirrhosis

HIV positive people with compensated liver cirrhosis related to chronic hepatitis C virus (HCV) responded as well to treatment with pegylated interferon and ribavirin as coinfected patients without cirrhosis, but they should receive closer monitoring and may need more intensive management of side effects. alt

Read more:

ICAAC 2011: Maraviroc May Reduce Liver Fibrosis in HIV/HCV Coinfected People

Adding the CCR5 blocker maraviroc (Selzentry) to an antiretroviral regimen reduced liver stiffness, an indicator of fibrosis, according to a study presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) this week in Chicago.

Read more:

Treating HIV/HBV Coinfection in Africa

Antiretroviral therapy regimens containing lamivudine did not provide notable benefit or reduce mortality among HIV/HBV coinfected patients in South African, suggesting that tenofovir (Viread) may be a better option.




Read more:

Hepatitis B and C Coinfection among HIV Positive People in the U.S.

Liver disease and coinfection with hepatitis B or C are common among people with HIV, according to a recent analysis, leading researchers to recommend that viral hepatitis screening, vaccination, and treatment should be considered a priority for HIV positive individuals.alt

Read more:

Gene Patterns Predict Fibrosis in HIV/HCV Coinfected People

Certain haplogroups, or gene pattern clusters, were associated with reduced risk of liver fibrosis among European patients with HIV and hepatitis C coinfection.

Read more: